Advances in oral controlled drug delivery: the role of drug–polymer and interpolymer non-covalent interactions

Bibliography

• Amidon GL, Lennernas H, Shah VP, Crison JR. A theoretical basis for a biopharmaceutic drug classification - the correlation of in-vitro drug product dissolution and in-vivo bioavailability. Pharm Res 1995;12(3):413-20
   PubMed Web of Science ®Google Scholar
• Mrsny RJ. Oral drug delivery research in Europe. J Control Release 2012;161(2):247-53
   PubMed Web of Science ®Google Scholar
• MP-Advisors. Innovative drug delivery systems opportunities for generic & specialty pharmaceutical companies. Available from: http://www.reportsnreports.com/reports/275193-innovative-drug-delivery-systems-opportunities-for-generic-specialty-pharmaceutical-companies.html 2014
   Google Scholar
• Das NG, Das SK. Controlle-release of oral dosage forms. Formulation Fill Finish 2003;10-16
   Google Scholar
• Crowley P, Martini L. Drug-excipient interactions. Pharm Techol Eur 2001;13(3):26-34
   Google Scholar
• Srikanth MV, Sunil SA, Rao NS, et al. Ion-exchange resins as controlled drug delivery carriers. J Sci Res 2010;2:597-611
   Google Scholar
• Anand V, Kandarapu R, Garg S. Ion-exchange resins: carrying drug delivery forward. Drug Discov Today 2001;17:905-14
   Google Scholar
• Ichikawa H, Fujioka K, Adeyeye MC, Fukumori Y. Use of ion-exchange resins to prepare 100 microm-sized microcapsules with prolonged drug-release by the Wurster process. Int J Pharm 2001;216:67-76
   PubMed Web of Science ®Google Scholar
• Shamma RN, Basalious EB, Shoukri RA. Development and optimization of a multiple-unit controlled release formulation of a freely water soluble drug for once-daily administration. Int J Pharm 2011;405:102-12
   PubMed Web of Science ®Google Scholar
• Pongjanyakul T, Prakongpan S, Rungsardthong U, et al. Characteristics and in vitro release of dextromethorphan resonates. Powder Technol 2005;152:100-6
   Web of Science ®Google Scholar
• Jeong SH, Park K. Drug loading and release properties of ion-exchange resin complexes as a drug delivery matrix. Int J Pharm 2008;361:26-32
   PubMed Web of Science ®Google Scholar
• Jeong SH, Park K. Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes. Int J Pharm 2008;361:195-204
   Google Scholar
• Bettini R, Colombo P, Peppas NA. Solubility effects on drug transport through ph-sensitive, swelling-controlled release systems - transport of theophylline and metoclopramide monohydrochloride. J Control Release 1995;37(1-2):105-11
   Web of Science ®Google Scholar
• Li L, Ni R, Shao Y, Mao S. Carrageenan and its applications in drug delivery. Carbohydr Polym 2014;103:1-11
   PubMed Web of Science ®Google Scholar
• Bonferoni MC, Rossi S, Tamayo M, et al. On the employment of lambda-carrageenan in a matrix system. 1. Sensitivity to dissolution medium and comparison with Na carboxymethylcellulose and xanthan gum. J Control Release 1993;26(2):119-27
   Web of Science ®Google Scholar
• Bonferoni MC, Rossi S, Ferrari F, et al. Characterization of a diltiazem-lambda carrageenan complex. Int J Pharm 2000;200(2):207-16
   PubMedGoogle Scholar
• Moreno-Villoslada I, Oyarzun F, Miranda V, et al. Binding of chlorpheniramine maleate to pharmacologically important alginic acid,carboxymethylcellulose, kappa-carageenan, and iota-carrageenan as studied by diafiltration. J Appl Polym Sci 2005;98:598-602
   Web of Science ®Google Scholar
• Pavli M, Baumgartner S, Kos P, Kogej K. Doxazosin-carrageenan interactions: a novel approach for studying drug-polymer interactions and relation to controlled drug release. Int J Pharm 2011;421(1):110-19
   PubMedGoogle Scholar
• Pavli M, Vrecer F, Baumgartner S. Matrix tablets based on carrageenans with dual controlled release of doxazosin mesylate. Int J Pharm 2010;400(1-2):15-23
   PubMedGoogle Scholar
• Bonferoni MC, Rossi S, Ferrari F, et al. Factorial analysis of the influence of dissolution medium on drug release from carrageenan-diltiazem complexes. AAPS PharmSciTech 2000;1(2):E15
   Google Scholar
• Bonferoni MC, Sandri G, Rossi S, et al. Polyelectrolyte-drug complexes of lambda carrageenan and basic drugs: relevance of particle size and moisture content on compaction and drug release behavior. Drug Dev Ind Pharm 2008;34(11):1188-95
   PubMed Web of Science ®Google Scholar
• Aguzzi C, Bonferoni MC, Fortich MR, et al. Influence of complex solubility on formulations based on lambda carrageenan and basic drugs. AAPS PharmSciTech 2002;3(3):E27
   Google Scholar
• Bettini R, Bonferoni MC, Colombo P, et al. Drug release kinetics and front movement in matrix tablets containing diltiazem or metoprolol/lamda-carrageenan complexes. BioMed Res Int 2014;2014:8
   Google Scholar
• Bonferoni MC, Rossi S, Ferrari F, et al. On the employment of lambda carrageenan in a matrix system. III. Optimization of a lambda carrageenan-HPMC hydrophilic matrix. J Control Release 1998;51(2-3):231-9
   PubMed Web of Science ®Google Scholar
• Li L, Wang L, Shao Y, et al. Elucidation of release characteristics of highly soluble drug trimetazidine hydrochloride from chitosan-carrageenan matrix tablets. J Pharm Sci 2013;102(8):2644-54
   PubMed Web of Science ®Google Scholar
• Rigo MVR, Allemandi DA, Manzo RH. Swellable drug-polyelectrolyte matrices of drug-carboxymethylcellulose complexes. Characterization and delivery properties. Drug Deliv 2009;16(2):108-15
   PubMed Web of Science ®Google Scholar
• Battistini FD, Olivera ME, Manzo RH. Equilibrium and release properties of hyaluronic acid-drug complexes. Eur J Pharm Sci 2013;49(4):588-94
   PubMed Web of Science ®Google Scholar
• Porcar L, Codoner A, Gomez CM, et al. Interactions of quinine with polyacrylic and poly-L-glutamic acids in aqueous solutions. Eur Polym J 2004;40(4):819-28
   Web of Science ®Google Scholar
• Boonsongrit Y, Mitrevej A, Mueller BW. Chitosan drug binding by ionic interaction. Eur J Pharm Biopharm 2006;62(3):267-74
   PubMed Web of Science ®Google Scholar
• Boonsongrit Y, Mueller BW, Mitrevej A. Characterization of drug-chitosan interaction by H-1 NMR, FTIR and isothermal titration calorimetry. Eur J Pharm Biopharm 2008;69(1):388-95
   PubMed Web of Science ®Google Scholar
• Ma ZS, Yeoh HH, Lim LY. Formulation pH modulates the interaction of insulin with chitosan nanoparticles. J Pharm Sci 2002;91(6):1396-404
   PubMed Web of Science ®Google Scholar
• Mao SR, Bakowsky U, Jintapattanakit A, Kissel T. Self-assembled polyelectrolyte nanocomplexes between chitosan derivatives and insulin. J Pharm Sci 2006;95(5):1035-48
   PubMed Web of Science ®Google Scholar
• Jintapattanakit A, Junyaprasert VB, Mao S, et al. Peroral delivery of insulin using chitosan derivatives: a comparative study of polyelectrolyte nanocomplexes and nanoparticles. Int J Pharm 2007;342(1-2):240-9
   PubMedGoogle Scholar
• Rodriguez R, Alvarez-Lorenzo C, Concheiro A. Interactions of ibuprofen with cationic polysaccharides in aqueous dispersions and hydrogels rheological and diffusional implications. Eur J Pharm Sci 2003;20(4-5):429-38
   PubMed Web of Science ®Google Scholar
• Bernkop-Schnurch A, Schuhbauer H, Clausen AE, Hanel R. Development of a sustained release dosage form for alpha-lipoic acid. I. design and in vitro evaluation. Drug Dev Ind Pharm 2004;30(1):27-34
   PubMed Web of Science ®Google Scholar
• Quinteros DA, Rigo VR, Kairuz AEJ, et al. Interaction between a cationic polymethacrylate (Eudragit E100) and anionic drugs. Eur J Pharm Sci 2008;33(1):72-9
   PubMed Web of Science ®Google Scholar
• Ramirez-Rigo MV, Olivera ME, Rubio M, Manzo RH. Enhanced intestinal permeability and oral bioavailability of enalapril maleate upon complexation with the cationic polymethacrylate Eudragit E100. Eur J Pharm Sci 2014;55:1-11
   PubMed Web of Science ®Google Scholar
• Palmer D, Levina M, Nokhodchi A, et al. The influence of sodium carboxymethylcellulose on drug release from polyethylene oxide extended release matrices. AAPS PharmSciTech 2011;12(3):862-71
   PubMed Web of Science ®Google Scholar
• Dabbagh MA, Ford JL, Rubinstein MH, et al. Release of propranolol hydrochloride from matrix tablets containing sodium carboxymethylcellulose and hydroxypropylmethylcellulose. Pharm Dev Technol 1999;4(3):313-24
   PubMed Web of Science ®Google Scholar
• Takka S. Propranolol hydrochloride-anionic polymer binding interaction. Farmaco 2003;58:1051-6
   PubMedGoogle Scholar
• Takka S, Rajbhandari S, Sakr A. Effect of anionic polymers on the release of propranolol hydrochloride from matrix tablets. Eur J Pharm Biopharm 2001;52(1):75-82
   PubMed Web of Science ®Google Scholar
• Palmer D, Levina M, Douroumis D, et al. Mechanism of synergistic interactions and its influence on drug release from extended release matrices manufactured using binary mixtures of polyethylene oxide and sodium carboxymethylcellulose. Colloids Surf B Biointerfaces 2013;104:174-80
   PubMed Web of Science ®Google Scholar
• Miyajima M, Koshika A, Okada J, et al. Effect of polymer crystallinity on papaverine release from poly (L-lactic acid) matrix. J Control Release 1997;49(2-3):207-15
   Web of Science ®Google Scholar
• Miyajima M, Koshika A, Okada J, Ikeda M. Effect of polymer/basic drug interactions on the two-stage diffusion-controlled release from a poly(L-lactic acid) matrix. J Control Release 1999;61(3):295-304
   PubMed Web of Science ®Google Scholar
• Moustafine RI, Zaharov IM, Kemenova VA. Physicochemical characterization and drug release properties of Eudragit (R) E PO/Eudragit (R) L 100-55 interpolyelectrolyte complexes. Eur J Pharm Biopharm 2006;63(1):26-36
   PubMed Web of Science ®Google Scholar
• Tsuchida E. Formation of polyelectrolyte complexes and their structures. J Macromol Sci Pure 1994;31(1):1-15
   Google Scholar
• Thunemann AF, Muller M, Dautzenberg H, et al. Polyelectrolyte complexes. Adv Polym Sci 2004;166:113-71
   Web of Science ®Google Scholar
• Moustafine RI, Kabanova TV, Kemenova VA, Van den Mooter G. Characteristics of interpolyelectrolyte complexes of Eudragit E100 with Eudragit L100. J Control Release 2005;103(1):191-8
   PubMed Web of Science ®Google Scholar
• Moustafine RI, Bukhovets AV, Garipova VR, et al. Comparative evaluation of new carriers for controlled drug delivery based on Eudragit EPO/L100 interpolyelectrolyte complexes. Pharm Chem J 2012;46(8):507-11
   Web of Science ®Google Scholar
• Moustafine RI, Bobyleva VL, Bukhovets AV, et al. Structural transformations during swelling of polycomplex matrices based on countercharged (meth)acrylate copolymers (EudragitR EPO/EudragitR L 100-55). J Pharm Sci 2011;100(3):874-85
   PubMed Web of Science ®Google Scholar
• Mustafin RI, Bilan AB, Bukhovets AV, Kemenova VA. Comparative Study of Structural and Compositional Changes of Polycomplex Matrices Based on Eudragit (R) Epo and Eudragit (R) L100. Pharm Chem J 2011;45(2):114-17
   Web of Science ®Google Scholar
• Mustafin RI, Bukhovets AV, Sitenkov AY, et al. Synthesis and characterization of a new carrier based on eudragit (R) Epo/S100 interpolyelectrolyte complex for controlled colon-specific drug delivery. Pharm Chem J 2011;45(9):568-74
   Web of Science ®Google Scholar
• Moustafine RI, Bukhovets AV, Sitenkov AY, et al. Eudragit E PO as a complementary material for designing oral drug delivery systems with controlled release properties: comparative evaluation of new interpolyelectrolyte complexes with countercharged eudragit L100 copolymers. Mol Pharm 2013;10(7):2630-41
   PubMed Web of Science ®Google Scholar
• Moustafine RI, Bodrov AV, Kemenova VA, et al. Drug release modification by interpolymer interaction between countercharged types of Eudragit (R) RL 30D and FS 30D in double-layer films. Int J Pharm 2012;439(1-2):17-21
   PubMedGoogle Scholar
• Moustafine RI, Margulis EB, Sibgatullina LF, et al. Comparative evaluation of interpolyelectrolyte complexes of chitosan with Eudragit (R) L100 and Eudragit (R) L100-55 as potential carriers for oral controlled drug delivery. Eur J Pharm Biopharm 2008;70(1):215-25
   PubMed Web of Science ®Google Scholar
• Moustafine RI, Salachova AR, Frolova ES, et al. Interpolyelectrolyte complexes of Eudragit (R) E PO with sodium alginate as potential carriers for colonic drug delivery: monitoring of structural transformation and composition changes during swellability and release evaluating. Drug Dev Ind Pharm 2009;35(12):1439-51
   PubMed Web of Science ®Google Scholar
• Prado HJ, Matulewicz MC, Bonelli P, Cukierman AL. Basic butylated methacrylate copolymer/kappa-carrageenan interpolyelectrolyte complex: preparation, characterization and drug release behaviour. Eur J Pharm Biopharm 2008;70(1):171-8
   PubMed Web of Science ®Google Scholar
• Prado HJ, Matulewicz MC, Bonelli PR, Cukierman AL. Preparation and characterization of controlled release matrices based on novel seaweed interpolyelectrolyte complexes. Int J Pharm 2012;429(1-2):12-21
   PubMedGoogle Scholar
• Gupta VK, Beckert TE, Deusch NJ, et al. Investigation of potential ionic interactions between anionic and cationic polymethacrylates of multiple coatings of novel colonic delivery system. Drug Dev Ind Pharm 2002;28(2):207-15
   PubMed Web of Science ®Google Scholar
• Moustafine RI. Role of macromolecular interactions of pharmaceutically acceptable polymers in functioning oral drug delivery systems. Russ J Gen Chem 2014;84(2):364-7
   Web of Science ®Google Scholar
• Mustafin RI. Interpolymer combinations of chemically complementary grades of eudragit copolymers: a new direction in the design of peroral solid dosage forms of drug delivery systems with controlled release (Review). Pharm Chem J 2011;45(5):285-95
   Web of Science ®Google Scholar
• Assaad E, Wang YJ, Zhu XX, Mateescu MA. Polyelectrolyte complex of carboxymethyl starch and chitosan as drug carrier for oral administration. Carbohydr Polym 2011;84(4):1399-407
   Web of Science ®Google Scholar
• de la Torre PM, Enobakhare Y, Torrado G, Torrado S. Release of amoxicillin from polyionic complexes of chitosan and poly(acrylic acid). study of polymer/polymer and polymer/drug interactions within the network structure. Biomaterials 2003;24(8):1499-506
   PubMed Web of Science ®Google Scholar
• de la Torre PM, Torrado G, Torrado S. Poly (acrylic acid) chitosan interpolymer complexes for stomach controlled antibiotic delivery. J Biomed Mater Res B Appl Biomater 2005;72(1):191-7
   PubMed Web of Science ®Google Scholar
• de la Torre PM, Torrado S, Torrado S. Interpolymer complexes of poly(acrylic acid) and chitosan: influence of the ionic hydrogel-forming medium. Biomaterials 2003;24(8):1459-68
   PubMed Web of Science ®Google Scholar
• Torrado S, Prada P, de la Torre PM, Torrado S. Chitosan-poly(acrylic) acid polyionic complex: in vivo study to demonstrate prolonged gastric retention. Biomaterials 2004;25(5):917-23
   PubMed Web of Science ®Google Scholar
• Bigucci F, Luppi B, Cerchiara T, et al. Chitosan/pectin polyelectrolyte complexes: selection of suitable preparative conditions for colon-specific delivery of vancomycin. Eur J Pharm Sci 2008;35(5):435-41
   PubMed Web of Science ®Google Scholar
• Abdelbary GA, Tadros MI. Design and in vitro/in vivo evaluation of novel nicorandil extended release matrix tablets based on hydrophilic interpolymer complexes and a hydrophobic waxy polymer. Eur J Pharm Biopharm 2008;69(3):1019-28
   PubMed Web of Science ®Google Scholar
• Park SH, Chun MK, Choi HK. Preparation of an extended-release matrix tablet using chitosan/Carbopol interpolymer complex. Int J Pharm 2008;347(1-2):39-44
   PubMed Web of Science ®Google Scholar
• Friciu M, Canh Le T, Ispas-Szabo P, Mateescu MA. Carboxymethyl starch and lecithin complex as matrix for targeted drug delivery: I. Monolithic mesalamine forms for colon delivery. Eur J Pharm Biopharm 2013;85(3 Pt A):521-30
   PubMed Web of Science ®Google Scholar
• Alvarez-Fuentes J, Caraballo I, Boza A, et al. Study of a complexation process between naltrexone and Eudragit® L as an oral controlled release system. Int J Pharm 1997;148:219-30
   Google Scholar
• Holgado MA, Iruin A, Alvarez-Fuentes J, Fernandez-Arevalo M. Development and in vitro evaluation of a controlled release formulation to produce wide dose interval morphine tablets. Eur J Pharm Biopharm 2008;70(2):544-9
   PubMed Web of Science ®Google Scholar
• Alvarez-Fuentes J, Fernandez-Arevalo M, Holgado MA, et al. Characterization of morphine coprecipitates: a biopharmaceutical study. Pharmazie 1994;49:834-9
   Web of Science ®Google Scholar
• Alvarez-Fuentes J, Fernández-Arévalo M, Holgado MA, et al. Morphine polymeric coprecipitates for controller release: elaboration and characterization. Drug Dev Ind Pharm 1994;20:2409-24
   Web of Science ®Google Scholar
• Papageorgiou GZ, Papadimitriou S, Karavas E, et al. Improvement in chemical and physical stability of fluvastatin drug through hydrogen bonding interactions with different polymer matrices. Curr Drug Deliv 2009;6:101-12
   PubMedGoogle Scholar
• Ozeki T, Yuasa H, Kanaya Y. Application of the solid dispersion method to the controlled release of medicine. 9. Difference in the release of flurbiprofen from solid dispersions with poly(ethylene oxide) and hydroxypropylcellulose and the interaction between medicine and polymers. Int J Pharm 1997;155(2):209-17
   Google Scholar
• Ozeki T, Yuasa H, Kanaya Y. Controlled release from solid dispersion composed of poly(ethylene oxide)-Carbopol (R) interpolymer complex with various cross-linking degrees of Carbopol (R). J Control Release 2000;63(3):287-95
   PubMed Web of Science ®Google Scholar
• Khutoryanskiy VV. Hydrogen-bonded interpolymer complexes as materials for pharmaceutical applications. Int J Pharm 2007;334(1-2):15-26
   PubMedGoogle Scholar
• Nanaki SG, Koutsidis IA, Koutri I, et al. Miscibility study of chitosan/2-hydroxyethyl starch blends and evaluation of their effectiveness as drug sustained release hydrogels. Carbohydr Polym 2012;87(2):1286-94
   Web of Science ®Google Scholar
• Clausen AE, Bernkop-Schnurch A. Direct compressible polymethacrylic acid-starch compositions for site-specific drug delivery. J Control Release 2001;75(1-2):93-102
   PubMed Web of Science ®Google Scholar
• Klouda L, Mikos AG. Thermoresponsive hydrogels in biomedical applications. Eur J Pharm Biopharm 2008;68(1):34-45
   PubMed Web of Science ®Google Scholar
• Coughlan DC, Quilty FP, Corrigan OI. Effect of drug physicochemical properties on swelling/deswelling kinetics and pulsatile drug release from thermoresponsive poly(N-isopropylacrylamide) hydrogels. J Control Release 2004;98(1):97-114
   PubMed Web of Science ®Google Scholar
• Coughlan DC, Corrigan OI. Drug-polymer interactions and their effect on thermoresponsive poly(N-isopropylacrylamide) drug delivery systems. Int J Pharm 2006;313(1-2):163-74
   PubMedGoogle Scholar
• Le Tien C, Lacroix M, Ispas-Szabo P, Mateescu MA. N-acylated chitosan: hydrophobic matrices for controlled drug release. J Control Release 2003;93(1):1-13
   PubMed Web of Science ®Google Scholar
• Costache AD, Sheihet L, Zaveri K, et al. Polymer-drug interactions in tyrosine-derived triblock copolymer nanospheres: a computational modeling approach. Mol Pharm 2009;6(5):1620-7
   PubMed Web of Science ®Google Scholar
• Machackova M, Tokarsky J, Capkova P. A simple molecular modeling method for the characterization of polymeric drug carriers. Eur J Pharm Sci 2013;48(1-2):316-22
   PubMed Web of Science ®Google Scholar
• Marsac PJ, Shamblin SL, Taylor LS. Theoretical and practical approaches for prediction of drug-polymer miscibility and solubility. Pharm Res 2006;23(10):2417-26
   PubMed Web of Science ®Google Scholar
• Elviri L, DeRobertis S, Baldassarre S, Bettini R. Desorption electrospray ionization high-resolution mass spectrometry for the fast investigation of natural polysaccharide interactions with a model drug in controlled release systems. Rapid Commun Mass Spectrom 2014;28(13):1544-52
   PubMed Web of Science ®Google Scholar
• Korsmeyer RW, Gurny R, Doelker E, et al. Mechanism of solute release from porous hydrophilic polymers. Int J Pharm 1983;15:25-35
   Web of Science ®Google Scholar
• Peppas NA, Sahlin JJ. A simple equation for the description of solute release. 3. coupling of diffusion and relaxation. Int J Pharm 1989;57(2):169-72
   Web of Science ®Google Scholar
• Tamimi F, Torres J, Bettini R, et al. Doxycycline sustained release from brushite cements for the treatment of periodontal diseases. J Biomed Mater Res A 2008;85(3):707-14
   PubMedGoogle Scholar
• Colombo P, Sonvico F, Colombo G, Bettini R. Novel platforms for oral drug delivery. Pharm Res 2009;26(3):601-11
   PubMed Web of Science ®Google Scholar